authors
- Giovannoni, G
- Foley, J
- Defer, G
- Ryerson, L Zhovtis
- Cohen, J
- Arnold, Donald
- Butzkueven, H
- Cutter, G
- Killestein, J
- Wiendl, H
- Sinks, S
- Steverson, J
- Dsilva, L
- Monine, M
- Sohn, J
- Ferraro, E
- Lasky, T
Serum neurofilament light chain levels during natalizumab treatment with every-4-week and every-6-week dosing in NOVA
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 2023
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- Neurology & Neurosurgery (Science Metrix)
published in
- European Journal of Neurology Journal